Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaginal Injection of Platelet Rich Plasma (PRP) for the Genitourinary Syndrome of Menopause (GSM)

NCT06028009 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT06028009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06028009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaginal Injection of Platelet Rich Plasma (PRP) for the Genitourinary Syndrome of Menopause (GSM)
Lead sponsor
Medstar Health Research Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 1, 2024
Completion date
April 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genitourinary syndrome of menopause, postmenopausal symptoms, prp, sexual function disturbances, vaginal atrophy